Katie
Analyst
TD Cowen
Equibles does not estimate personal net worth.
About Katie
Katie is recorded as Analyst at TD Cowen. Katie has spoken on 1 investor event across 1 company, most recently for Assembly Biosciences, Inc. on June 8, 2026. The companies whose calls Katie spoke on are classified in the Healthcare sector.
Katie on recent calls
“Yeah, so, you know, I think just kind of stepping back and thinking about the patient population, it's a pretty underserved population overall. You know, there have not been any new advancements for recurrent genital herpes in over 30 years, and as Jason said, Valtrex is the standard of care.”
Affiliation history
-
TD Cowen
Analyst
Transcript header (unverified)
Current